drugset / Trial / NCT03564782
Examining Bioactivity of PVSRIPO in Invasive Breast Cancer
Phase 0
Completed
5 enrolled
Istari Oncology, Inc.
Duke University · collabUnited States Department of Defense · collab
NaSingle-groupOpen-labelBasic science
Summary
This is a pilot study to examine PVSRIPO bioactivity in tumor tissue after intratumoral administration of PVSRIPO in women with invasive breast cancer.
Timeline
- Start
- 2019-06-30
- Primary completion
- 2022-04-11
- Completion
- 2022-04-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PVSRIPO | Other / unclassified | 1e+08 unknown | Oral |